Introduction
Over the last few years many advances have been made in the identification of cytochrome P-450 isoenzymes and GSTs. There are now many studies that demonstrate that isoenzymes of both of these groups of proteins play very different roles in both the activation of foreign compounds to toxic and carcinogenic products as well as their deactivation. In this respect it is extremely important to understand the factors that regulate the concentrations of particular isoenzymes within the liver and other tissues.
It has been known for many years that many enzymes are distributed unevenly in the hepatocyte population of the liver lobes. The distribution of drug metabolizing enzymes is potentially very important as a cell which contains a high concentration of P-450 may contain very low concentrations of the GSTs, making that cell particularly susceptible to certain chemicals activated by the P-450 system. There are now reports on the localization of cytochrome P-450 components in the liver, and other tissues, that demonstrate cell specific localizations (Serabjit-Singh et al., 1979; Dees et al., 1982; Baron & Kawabata, 1983) . In this study we have isolated and characterized four different cytochrome P-450
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isoenzymes (two from PB-treated rat liver and two from rats treated with 3-MC), two major forms of the GSTs and hepatic microsomal EH in order to investigate their regulation relative to each other. Several experimental approaches have been taken. These are the immunochemical quantification of isoenzyme concentration in hepatic microsomal samples from animals treated with different inducing agents, the..immunochemical localization of these isoenzymes in serial sections of rat liver, the effect of inducing agents on these levels and the regulation of these isoenzymes in preneoplastic foci during experimental hepatocarcinogenesis.
Materials and methods
Cytochrome P-450 isoenzymes (PB,, PB2, MC, and MC,), GST Band C and EH were purified from the livers of male Sprague-Dawley rats (180-2OOg) using methods previously described (Bentley & Oesch, 1975; Friedberg et al., 1983; Wolf & Oesch, 1983) . Antibodies to these proteins were raised in rabbits using reported procedures (Wolf & Oesch, 1983) . Immunohistochemical localizations were carried out on either paraffin sections or frozen sections fixed with benzoquinnone. A double-antibody procedure was used; the second antibody was labelled with horseradish peroxidase. Peroxidase activity was visualized by incubation of the sections with 3,3'-diaminobenzidine and Male or female Sprague-Dawley rats (1 50-200g) were used for all enzyme quantification and localization studies. Certain groups of animals were treated with PB, 3-MC, Iso, Clo, /?-NF, TSO, ARO or PCN using conventional induction schedules for maximal induction of the cytochrome P-450 isoenzymes.
Preneoplastic lesions were induced in the livers of 70g female rats by using DEN (50 or 100 p.p.m.) in the drinking water for 10 days or by continuous treatment with either DEN (10mg/kg) or DMN (3mg/kg) by stomach tube 5 days a week for up to 22 weeks. Carcinogen treatment was stopped 14 days before preparation of the tissue samples.
1984

H202.
Cytochrome P-450 isoenzyme concentration was estimated in hepatic microsomal preparations from animals treated with a variety of inducing agents (see above) using an ELISA (Wolf & Oesch, 1983) .
Results and discussion
Certain properties of the cytochrome P-450 preparations used in this study are shown in Table 1 . These data demonstrate that all the isolated forms represent distinct forms of cytochrome P-450. Form PB, does not appear to have been previously described. It is of interest that nearly all antibodies reacted preferentially with their homologous antigen; however, they almost all cross-reacted to some extent with the other cytochrome P-450 isoenzymes. This indicates either the presence of common antigenic determinants on all of these proteins and therefore some structural similarities between all P-450s, or the presence of common impurities in the cytochrome preparations. The latter possibility could not be substantiated by SDS-gel electrophoresis of the purified antigens and is therefore an unlikely explanation for this effect. A cross-reaction between MC, and MC, (forms d and c) has already been reported (Ryan et al., 1982) .
The relative proportions of the cytochrome P-450 isoenzymes in rat liver following treatment of the animals with various inducing agents is shown in Table 2 . Both PB, and PB, were induced by PB, TSO and ARO. A similar observation was made for MC, and MC, which were both induced by 3-MC, Is0 and ARO. Clo did not induce any of these proteins and in fact resulted in a decrease in their synthesis. These data suggested that groups of P-450 isoenzymes are under similar control. The extent of induction of the isoenzymes, however, varied between inducing agents; for example, PB induced PB, approximately 5-fold but PB, was induced 12-fold. In other cases PB, and PB, were induced equally, e.g. in TSO-treated animals. It was interesting to note that Is0 appeared to induce PB,, MC, and MC, considerably whereas only a marginal increase in PB, was observed. The induction profiles measured using the ELISA were confirmed in the histochemical localization studies (see below). There are other reports in the literature on quantification of P-450 isoenzymes in rat liver microsomal samples (Guengerich et al., 1982; Ryan et al., 1982) and considerable variations in the isoenzyme patterns are reported. Some of these variations could be ascribed to the age, sex and strain of rats used as well as differences in the 'control' enzyme levels and the extent of induction. The cross-reactivity of the antibodies with each other, observed using the highly sensitive ELISA method (Table l) , is also a complicating factor and ideally such studies should be carried out with isoenzyme-specific monoclonal antibodies. At present it is not possible to adjust for the cross-reactivity of an antibody to a particular isoenzyme for reactivity with other cytochrome forms as not all forms have been identified. This fact could account for the finding that in some cases the summed isoenzyme content was higher than the cytochrome content determined from the carbon monoxide difference spectrum ( Table 2 ). The presence of haem-free protein is another possible explanation for this effect. The data presented in Table 2 , however, does clearly demonstrate that cytochrome P-450 isoenzymes are regulated differentially. Whether these differences were also reflected in the distribution of these proteins in hepatocytes and how the P-450 isoenzymes are localized relative to the GSTs, EH and P-450 reductase is shown in Baron & Kawabata, 1983) .
In the livers from control animals, only very low enzyme Table 1 . Summary of the data for the cytochrome P-450 forms investigated Immunochemical cross-reactivity was determined using an ELISA. The stock cytochrome P-450 solutions were 5 pg protein ml-l . lop1 was taken for each determination. Bound antibody was assayed using perohidase-labelled anti-rabbit IgG as described previously (Wolf & Oesch, 1983 ). ND = not detectable; 7-EC = 7-ethoxycoumarin; 7-ERF = 7-ethoxyresorufin. Literature nomenclatures were from: *Ryan et al. (1982) ; **Guengerich et al. (1982) .
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Values from 1 to 8 represent a visual assessment of the relative staining intensity, Where no value is given staining was not increased above control sections treated with pre-immune serum. c = centrilobular; m = midzonal; p = periportal. PB and 3-MC refer to liver sections from animals treated with these compounds.
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concentrations were found in the midzonal region and none were detectable in the periportal region. In these sections many cells that contained PB,, especially towards the midzonal region, were devoid of PB2. This interesting finding suggests that although these enzymes are induced by similar compounds ( Table 2) there must be some basic differences in their regulation. The case was the same for MCI and MC,. The effect of various inducing agents (3-MC, PB, Iso, ARO, PCN, j -N F and Clo) on the distribution of the drug metabolizing enzymes was investigated and the results obtained using PB and 3-MC are shown in Table 3 . The isoenzymes whose staining intensity was increased in the liver sections after treatment with specific inducing agents closely followed the pattern of induction measured in the ELISA ( Table 2 ). In most cases the inducing agents did not alter the distribution of the enzymes substantially, a slight broadening of the staining into the midzonal region for most of the isoenzymes was measured. A few exceptions, however, are worthy of note: 3-MC caused a general increase in MC, levels throughout the liver lobule and unlike most of the isoenzymes gave significant staining in the periportal region. No GSTs could be detected in this area. This indicates that these cells may be particularly susceptible to the effects of compounds activated by MC2 to products that are normally deactivated by the GSTs, e.g. the polycyclic aromatic hydrocarbons. B-NF, which also induces P-450 MC,, in contrast to 3MC caused large increases in MC, concentration specifically in the periportal region indicating that either MC2 concentration is regulated by more than one mechanism or that factors such as inducer uptake and the pharmacokinetics of the inducing agent may play a role in the site of induction.
On induction with Iso, MC, and MC, were localized in different hepatocyte populations; these were centrilobular and periportal for MCI and MC2, respectively. This again demonstrates the differential regulation of these proteins. Many hepatocytes in the midzonal region contained GST B but no apparent GST C . In general, all of the drug metabolizing enzymes investigated in this study are regulated by different, but perhaps overlapping, mechanisms. These conclusions were confirmed when the isoenzyme concentrations were measured in nitrosamine-induced preneoplastic foci in rat liver at various stages of hepatocarcinogenesis. The concentration of the GSTs and EH were significantly increased at all the stages measured, i.e. up to 34 weeks after carcinogen exposure. The islet Concentration of PBI and PB,, as well as MC, and MC,, concentration decreased steadily with the progression of the lesions. MC, concentration decreased at a faster rate than the other isoenzymes. In preneoplastic nodules the concentrations of four cytochromes was very low, yet the GST and EH concentrations were still high. These data clearly distinguish between the regulatory mechanisms for the GSTs and EH and those for the P-450 isoenzymes.
In conclusion these studies demonstrate that the regulation of drug metabolizing enzyme concentration within cells is very complex. The differential distribution of the P-450 isoenzymes and GST isoenzymes and their control within hepatocytes, and the cells of other tissues, must be considered an important factor in the reactions of chemical toxins and carcinogens.
